Dr. Cornacchia is the founder of DocPatientNetwork, Inc. as well as a practicing neurosurgeon and department chair. Dr. Cornacchia’s passion has always combined medicine and technology, both for the benefit of the healthcare industry, its physicians and its patients.
As a H.S. student he worked with Dr. Jacques Padawer in the Dept. of Anatomy at Albert Einstein College of Medicine, publishing an abstract on adjuvant therapy of CH3 mammary tumors with lucanthone and nitrogen mustard. While attending Columbia College (’82) he worked at Columbia P&S to publish an abstract on striated muscle fiber contraction kinetics with Professor Massataka Kawai. At Columbia, he also worked with Salvatore DiMauro and Sara Shanske and developed a technology for more efficiently dispensing centrifuged blood components and assisted in the research to ultimately demonstrate that certain diseases involving acid maltase deficiency can be diagnosed from a blood sample.
Dr. Cornacchia studied medicine at the NYU School of Medicine, graduating in 1987, with honors in cell biology for developing a comprehensive stereological analysis package in Fortran for analysis of electron micrograph data with Dr. Virginia Black. He then employed this technology in the study of Pompe’s disease and published work demonstrating abnormality in the peroxisome in patients afflicted with this disease. During his last year of medical school, he worked with Dr. Joseph Ransohoff and Dr. Rodolfo Llinas researching clinical applications of magneto-encephalography. At the NYU magneto-encephalography lab he analyzed ambient magnetic noise patterns and identified a prominent source of magnetic noise leading to a tool for noise cancellation and substantially improving data quality in the lab. He also participated in early research to localize the P200 auditory signal in Heschl’s gyrus in human subjects.
Dr. Cornacchia completed his internship and residency in neurosurgery at the University of California, San Diego in 1996 under John Alksne, M.D. While in residency training he developed and patented a device for automated injection of radionuclide during seizures to help facilitate imaging studies that can help localize the source of seizures in patients with epilepsy. He also developed a technique for visualizing brain cortical activity using voltage-dependent dies. He performed clinical research with Hoi Sang U demonstrating changes in cerebral blood volume before, during and after interventions for treatment of cerebral arteriovenous malformations. He also worked with Michael Swensen helping to define an electrodiagnostic technique for diagnosis of tarsal tunnel syndrome which was presented as an abstract.
After residency, Dr. Cornacchia founded New York Neurosurgery & Neuroscience Associates, PLLC and used his experience to help direct Mercy Medical Center to become one of the first hospitals in NY to install a Gamma Knife Center. Utilizing his medical and technology experience he also developed MiMS, a complete Electronic Health Record(EHR); Practice Management (PM); Revenue Cycle Management (RCM) System solution, which was used to run multiple medical practices from 1997 to 2001.
Dr. Cornacchia is a clinical assistant professor of Neurosurgery at Cornell-Weill Medical Center and at SUNY Downstate Medical Center. He is also chief of Neurosurgery at Brookdale University Hospital Medical Center in Brooklyn, New York where he has helped establish a "bloodless surgery" program. Lou is active in the American Association of Neurological Surgeons, the Congress of Neurosurgery, the American Medical Association and state/county medical organizations. He has published papers in several scientific and medical journals, including the Journal of Biophysics, The American Journal of Anatomy, Computers in Biology and Medicine, Muscle and Nerve, and the American Academy of Clinical Neurophysiology.
In 2001, Dr. Cornacchia undertook a massive project to begin development of a unique software platform for physicians and other providers, patients, hospitals, payers and government agencies designed to go beyond the limitations of siloed client-server based technologies which are still de reguer today. In 2005 he founded DocPatientNetwork, Inc (DPN) to engineer highly scalable “collaboration” technology designed to coerce the healthcare system towards reduced global healthcare costs and dramatically improved quality of care. His current research focus is in the application of multi-tenancy software architectures to solve stake-holder alignment, communications and interoperability issues in healthcare. This technology includes Internet-native web applications called 1) Doctations, which provides physicians with low-cost, comprehensive, extremely powerful EHR, PM, RCM and Internet Social Networking services online; 2) iMedicalHome which provides patients with a complete health care management platform online, including a state-of-the-art Patient Health Record; 3) iBillWell which provides patients, doctors, hospitals and other organizations with a complete Revenue Cycle Management and claims managements system online and 4) iTranscribe which provides very flexible dictation/transcription services online. His current research interests are the area of using the DPN multi-tenancy technology to help build a paradigm shift in healthcare by catalyzing stakeholder alignments in the healthcare industry to provide maximum possible quality of life and longevity for patients at the lowest possible cost.
Louis Cornacchia, Sr. (Director) received his BSEE from Manhattan College School of Engineering. He was employed at Hazeltine Electronics as an engineer and designed a signal processor and radar display system for the SAGE system, the TPS-1 ground-based search radar system and AWACS power systems. He was chief engineer at Victory Electronics in charge of development of night vision systems for the Fort Dix Army Command. He founded Collins Consultants Int´l LTD in 1969 to provide specialized engineering services in both the nuclear and military/industrial technology communities. Mr. Cornacchia founded Scinetix in 1987 to provide frequency environmental impact studies to Westinghouse Corp., Martin Marietta, IBM, and Grumman Corp., among many others. Scinetix also provides mobile radio cellular EMF/ antenna design studies for most of the cellular companies in the NY tri-state region. Mr. Cornacchia is a member of the board of directors of several companies, including Reliance Bank and Axonyx Corporation. He is a member of the advisory board of Patriot National Bank.
Steven B. Ratoff (Director) received his B.S. in Business Administration from Boston University and an M.B.A. with Distinction from the University of Michigan. Mr. Ratoff began his career at Arthur Anderson and Co. where he worked from 1965-1975. He joined Bristol Myers and was there until 1991 where his last position was EVP and CFO of the Bristol Myers Squibb Pharmaceutical Group. He then moved to Brown-Forman Corp. where he was EVO and CFO until 2001. Since December, 2004 he has served as a venture partner with ProQuest Investments, a healthcare venture capital firm. Mr. Ratoff serves on the Board of several public and privately held corporations.
Brian G. Sweeney (Director) received his B.S. in computer science from the University of Virginia and his M.B.A. in finance from the University of Pennsylvania. Mr. Sweeney currently serves as senior vice president of eMedia for Cablevision Systems, a position he has held since 2000. He is actively engaged in evaluating emerging technologies and developing next-generation systems architectures for multi-platform applications and services. He joined Cablevision in 1993 and served as vice president of information systems for subsidiary Rainbow Media Holdings. Mr. Sweeney also serves as a board member of Cablevision and several private organizations.
James C. Walsh, Esq. (Director), graduated from the University of Alabama (59) and University of Alabama Law School (66). He is a member of the New York and Louisiana Bar Associations. Mr. Walsh is currently President of Namanco Productions, Inc., specializing in the marketing and management of professional athletes and entertainers. During the course of his professional career, Mr. Walsh has served as director for several public companies including Vestin Mortgage and CBS Sportsline?, where he was instrumental in raising first-round funding. Mr. Walsh is married to Yvonne LaFleur, a successful retail operator and clothing designer who, for the past 30 years, has owned and operated her namesake ladies retail store Yvonne LaFleur in New Orleans.
Mr. Peter Benton is the Director of the Patient Advisory Board. He was born in Minnesota and has lived in the Midwest and New York City. Mr. Benton received a BS in Computer Science from the City College of New York, School of Engineering and an MBA from Bradley University in Peoria, Illinois. He has worked as a business analyst for Caterpillar Tractor Company, a senior consultant and manager for Arthur Andersen & Company, a developer of electronic and online information products, executive for planning and business development and Chief Scientist for McGraw-Hill, Inc. For nearly two decades, he has been a self-employed service architect and development consultant for a range of Internet-based businesses and social service organizations. Committed to cooperative action, he was a five-year member of the American National Standards Institute (ANSI) Board of Standards Review and is a long-time member of the Park Slope Food Coop, The Park Slope Singers and the Three Arrows Cooperative Society. He is co-author of the book The Cost and Price of the Customer’s Experience and scripted a video Training for Feeding Assistants (nursing home staff) published by Innovations Services. Mr. Benton prepared grant requests that raised more than $1 million for two nursing home chains. He has been a healthcare proxy, proxy consultant and estate administrator for several people with chronic and terminal health problems.
The DocPatient Network project recognized early on the importance of including all stakeholders in the research and development process. The Advisory boards were established approximately four years ago to serve this purpose. In fact, the four-pod design of the Doctations interface was a direct result of discussion with the first three advisory boards.
Members of the advisory board serve a on a voluntary basis without salary. Advisory board members have been awarded stock options in the past for their contributions.
The Physician Advisory Board is the first advisory board assembled by the Doctations project. This advisory board consists exclusively of doctors, nurses, physician assistants, and nurse practitioners who provided insights on the Doctations system from the healthcare provider’s point of view. This group’s purpose is to prepare recommendations regarding inclusion of new functionality consistent with the primary goal of Doctations to empower and strengthen the doctor-patient relationship.
The Patient Advisory Board was initiated approximately three months after initiating the Physician Advisory Board, based on a recommendation of physicians on that board. Patient members have provided important insights on Doctations and iMedicalHome features to benefit families and patients with chronic illness or requiring special care on an ongoing basis.
The Business Advisory Board consists of members of the healthcare business community such as hospital executives, insurance company executives, bank executives, billing service company executives, pharmaceutical company executives and transcription company executives. This group has provided insights into the roles that the Doctations web based EMR and web based medical billing software must fill for the various stakeholders. Its ongoing mission is to provide guidance in our effort to catalyze positive change in the healthcare industry by strengthening the doctor patient relationship and the role of the physician in healthcare reform.
The Legal Advisory Board consists of attorneys in every aspect of medical law including HIPAA, medical-legal issues, malpractice, and medical corporate law. These attorneys have stressed the importance of achieving levels of privacy substantially above the HIPAA law. These attorneys have also provided valuable insights into the designed requirements needed to achieve compliance in multiple areas of medical law.
Members of all advisory boards serve on a volunteer basis without remuneration. Advisory board members are periodically rewarded with stock options for their contributions.
Please contact us if you would like additional information on our Board of Advisors or Advisory Boards.